DE69920683D1 - Selektiv auf den cb2-rezeptor wirkende cannabinoide - Google Patents

Selektiv auf den cb2-rezeptor wirkende cannabinoide

Info

Publication number
DE69920683D1
DE69920683D1 DE69920683T DE69920683T DE69920683D1 DE 69920683 D1 DE69920683 D1 DE 69920683D1 DE 69920683 T DE69920683 T DE 69920683T DE 69920683 T DE69920683 T DE 69920683T DE 69920683 D1 DE69920683 D1 DE 69920683D1
Authority
DE
Germany
Prior art keywords
receptor
selective
cannabinoids
cannabinoid
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69920683T
Other languages
English (en)
Other versions
DE69920683T2 (de
Inventor
Alexandros Makriyannis
Atmaram Khanolkar
Dai Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Connecticut
Original Assignee
University of Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Connecticut filed Critical University of Connecticut
Application granted granted Critical
Publication of DE69920683D1 publication Critical patent/DE69920683D1/de
Publication of DE69920683T2 publication Critical patent/DE69920683T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69920683T 1998-05-04 1999-05-04 Selektiv auf den CB2-Rezeptor wirkende Cannabinoide Expired - Fee Related DE69920683T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8412998P 1998-05-04 1998-05-04
US84129P 1998-05-04
PCT/US1999/009806 WO1999057107A2 (en) 1998-05-04 1999-05-04 Cannabinoids selective for the cb2 receptor

Publications (2)

Publication Number Publication Date
DE69920683D1 true DE69920683D1 (de) 2004-11-04
DE69920683T2 DE69920683T2 (de) 2005-04-07

Family

ID=22183058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920683T Expired - Fee Related DE69920683T2 (de) 1998-05-04 1999-05-04 Selektiv auf den CB2-Rezeptor wirkende Cannabinoide

Country Status (7)

Country Link
US (1) US6166066A (de)
EP (1) EP1076653B1 (de)
AT (1) ATE277921T1 (de)
CA (1) CA2340444A1 (de)
DE (1) DE69920683T2 (de)
ES (1) ES2224658T3 (de)
WO (1) WO1999057107A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE247097T1 (de) * 1998-05-04 2003-08-15 Univ Connecticut Analgetische und immunomodulierende cannabinoiden
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US20070179135A1 (en) * 2006-01-05 2007-08-02 Travis Craig R Cannabinoid derivatives
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
DE60033834T2 (de) 1999-10-18 2007-11-15 The University Of Connecticut, Farmington Für periphäre cannabinoid-rezeptoren selektive liganden
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US7235584B2 (en) * 2000-06-22 2007-06-26 Pharmos Corporation Non-psychotropic cannabinoids
JP2004501145A (ja) 2000-06-22 2004-01-15 ファーモス コーポレイション 向精神作用をもたない新規なカンナビノイド
CA2435409A1 (en) * 2001-01-26 2002-08-01 University Of Connecticut Novel cannabimimetic ligands
CA2436133A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
EP1414775B1 (de) * 2001-07-13 2012-12-19 The University of Connecticut Bicyclisches cannabinoid
US7666867B2 (en) * 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
US20040259936A1 (en) * 2001-12-07 2004-12-23 Nagarkatti Leonard C Treatment of neoplasia
CA2478338A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
WO2004103410A1 (en) * 2002-06-06 2004-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
WO2004017922A2 (en) 2002-08-23 2004-03-04 University Of Connecticut Keto cannabinoids with therapeutic indications
IL160420A0 (en) * 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
WO2005123053A2 (en) * 2004-06-22 2005-12-29 Pharmos Limited Use of cb2 receptors agonists for the treatment of huntington’s disease
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
US9575319B2 (en) 2014-03-10 2017-02-21 Ion Virtual Technology Corporation Method and system for reducing motion blur when experiencing virtual or augmented reality environments
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
DK3509638T3 (da) 2017-06-20 2022-04-11 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Præparater med cannabidiolsyreestere og anvendelser deraf
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
EP3937925A1 (de) 2019-03-12 2022-01-19 EPM (IP), Inc. Cannabidiolsäureesterzusammensetzungen und verwendungen davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US3886184A (en) * 1973-08-03 1975-05-27 Lilly Co Eli Aminodibenzo(b,d)pyrans
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5440052A (en) * 1993-08-06 1995-08-08 University Of Connecticut Compositions useful as a cannabinoid receptor probe
FR2735774B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
US5688825A (en) * 1996-05-31 1997-11-18 University Of Connecticut Anandamide amidase inhibitors as analgesic agents
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
ATE247097T1 (de) * 1998-05-04 2003-08-15 Univ Connecticut Analgetische und immunomodulierende cannabinoiden

Also Published As

Publication number Publication date
WO1999057107A2 (en) 1999-11-11
ES2224658T3 (es) 2005-03-01
US6166066A (en) 2000-12-26
WO1999057107A3 (en) 2000-02-03
EP1076653B1 (de) 2004-09-29
DE69920683T2 (de) 2005-04-07
ATE277921T1 (de) 2004-10-15
CA2340444A1 (en) 1999-11-11
EP1076653A2 (de) 2001-02-21

Similar Documents

Publication Publication Date Title
ATE277921T1 (de) Selektiv auf den cb2-rezeptor wirkende cannabinoide
ID26697A (id) Pemurnian neurotrofin
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
ATE175198T1 (de) N-acylierte trizyklische azaheteroringe verwendbar als vasopressin-antagonisten
TR200000782T2 (tr) Resorsinol türevleri.
ATE254456T1 (de) Cannabinoid-rezeptor-antagonisten
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
DE69910373D1 (de) Analgetische und immunomodulierende cannabinoiden
NO964236D0 (no) Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi
AR002459A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
ATE270663T1 (de) Trizyklische 1-benzylpyrazol-3- carbonsäurederivate als cannabinoidrezeptorantagonisten
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
DZ1468A1 (fr) Composés nouveaux.
ATE289810T1 (de) Ecteinascidinderivate
ES8505539A1 (es) Procedimiento para la obtencion de derivados de alcohol bencilico con propiedades sebosupresoras
EA199700242A1 (ru) Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора
DK0983275T3 (da) Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
TR199801612T2 (xx) Benzotiofen, benzotiofen i�eren form�ller ve y�ntemler.
EA199800949A1 (ru) Антибактериальные соединения карбапенема, содержащие их фармацевтические композиции и способы лечения
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
AR012249A1 (es) Compuestos de amonio cuaternario, procedimiento para su preparacion, composicion farmaceutica que los contiene, y su uso para la preparacion de medicamentos
AR004719A1 (es) Compuestos debisindolilmaleimidas con un punte n, n' y formulaciones farmaceuticas que los contienen, dichos compuestos son utiles comointermediarios para preparar otras bisindolilmaleimidas que poseen dicho puente n, n'
ES2167725T3 (es) Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee